RT Journal Article
SR Electronic
A1 Buckley, Rita
T1 Eplerenone Post Myocardial Infarction Plus Standard Treatment May Prevent Adverse Cardiovascular Outcomes
JF MD Conference Express
YR 2013
FD SAGE Publications
VO 13
IS 2
SP 20
OP 21
DO 10.1177/155989771302012
UL http://mdc.sagepub.com/content/13/2/20.abstract
AB Early administration of eplerenone added to standard treatment in postmyocardial infarction patients appears to reduce the risk of adverse cardiovascular outcomes and heart failure, according to results from the Impact of Eplerenone on Cardiovascular Outcomes in Patients Post-Myocardial Infarction trial [REMINDER; NCT01176968].